Cassava Sciences enters consulting agreement with former CEO Remi Barbier

FILANA THERAPEUTICS, INC.

Consulting agreement effective Sep 13, 2024 for one year, with potential one-year extension.
Barbier to provide support for scientific research and regulatory approval at $100 per hour.
Confidentiality, non-disparagement, and cooperation terms apply; severance benefits unchanged.
Barbier may only communicate with CEO or CFO; no contact with other employees without permission.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.